Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
ImmunityBio, Inc. seeks a Senior Backend Software Architect to drive technical excellence across the organization. This hybrid role blends hands-on development with high-level system architecture and leadership.
You will design scalable, secure, production-grade systems and mentor engineering teams, aligning technical solutions with business goals. The position requires deep full-stack expertise and experience designing enterprise-grade architectures, with the ability to bridge business
ImmunityBio is a vertically integrated commercial stage biotechnology company developing next-generation therapies that bolster the natural immune system to defeat cancers and infectious diseases. The Company’s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. Designated an FDA Breakthrough Therapy, ANKTIVA is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS that activates NK cells, T cells, and memory T cells for a long-duration response. The Company is applying its science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.
ImmunityBio is a vertically integrated commercial stage biotechnology company developing next-generation therapies that bolster the natural immune system to defeat cancers and infectious diseases. The Company’s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. Designated an FDA Breakthrough Therapy, ANKTIVA is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS that activates NK cells, T cells, and memory T cells for a long-duration response. The Company is applying its science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.
The Senior Backend Software Architect will drive technical excellence across our organization. This hybrid role combines hands-on software development with high-level system architecture and strategic technical leadership. You will design scalable, resilient systems while writing production-grade code, mentoring engineering teams, and serving as the technical bridge between business objectives and engineering execution. This role possesses deep full-stack expertise, proven experience designing enterprise-grade architecture, and the communication skills to align technical solutions with business goals.